Differential proteomic alterations between localised and metastatic prostate cancer. - sprookjes - yvandenbroek - TriplyDB

Differential proteomic alterations between localised and metastatic prostate cancer.

Differential proteomic alterations between localised and metastatic prostate cancer.

http://www.wikidata.org/entity/Q36553042

about

Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect.TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer A changing landscape in castration-resistant prostate cancer treatment Human prostatic acid phosphatase: structure, function and regulation.Recurrent nested stromal epithelial tumor of the liver with extrahepatic metastasis: case report and review of literature.Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: an insight for oncologists.Sipuleucel-T for the treatment of metastatic prostate cancer: promise and challenges.Metastatic castration-resistant prostate cancer: time for innovation.The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migration.Oncolytic virus-initiated protective immunity against prostate cancer Noninvasive multiparametric imaging of metastasis-permissive microenvironments in a human prostate cancer xenograft Lack of prognostic significance of prostate biopsies in metastatic androgen independent prostate cancer

P2860

Q35025058-D31CB5B5-46A2-49BD-8A74-F4A467EE7BC1 Q35710117-F83616E5-CA83-40C0-88B2-785B292B9EBF Q36101308-0C58C81A-0098-4E75-BF16-237D760B680B Q36913762-3A3DCD51-5CBE-489D-9B05-4FB659BFCD98 Q37109527-97838553-D9FF-412C-B70E-E0384256679A Q37905606-D1D1311E-71EB-477E-B035-38A209148E8F Q37984189-C903A8A9-B864-466F-84BF-B8382DFB423A Q38312041-A6B3245D-AB66-4B30-A03D-04E8113DDCD5 Q39359295-029124DC-258D-4C00-A1D1-803170B10DD0 Q39606073-B21C4902-A617-475A-A056-485BA322446B Q39782755-7B490CE3-957F-419A-A766-EAC52ACCE850 Q57660048-B4BA8AC1-110F-4933-93E1-84C4FFD920F4

P2860

Differential proteomic alterations between localised and metastatic prostate cancer.

http://www.wikidata.org/entity/Q36553042

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Differential proteomic alterations between localised and metastatic prostate cancer.

@ast

Differential proteomic alterations between localised and metastatic prostate cancer.

@en

type

label

Differential proteomic alterations between localised and metastatic prostate cancer.

@ast

Differential proteomic alterations between localised and metastatic prostate cancer.

@en

prefLabel

Differential proteomic alterations between localised and metastatic prostate cancer.

@ast

Differential proteomic alterations between localised and metastatic prostate cancer.

@en

P1433

Q36553042-0992B14C-909E-4738-BEA7-6595B67B0802

P1476

Q36553042-8941F81B-4DFE-4D1E-B470-9B31B7C1FFFF

P2093

Q36553042-50E1E9DE-CA86-4A77-AFD7-2EAA7883F77A

Q36553042-64AD24BA-2A85-4EBB-9592-85998D03A0AB

P2860

Q36553042-04D8C148-15F8-486D-9A1C-08BD96F758AC

Q36553042-07585CCB-09E3-4C03-B824-26763A46B606

Q36553042-1693B433-9527-4BAF-9BEB-8CE34B4424CB

Q36553042-1A5B7E8D-001D-403B-A300-C22021C0EC36

Q36553042-1CCD488E-B4A7-4ED6-8F19-2AF31A42D1B7

Q36553042-203F1155-9491-4C04-BD77-F7BD80419D28

Q36553042-20B26E42-23D4-4B58-BBDB-912D9A239675

Q36553042-28731D80-CB51-4FA5-A2FE-A6B12AD209E1

Q36553042-2E8AF941-82B6-4B18-949A-B21CA014F083

Q36553042-346041D9-76FA-42E8-A41C-62270C114272

P2888

Q36553042-D79368A5-FEBE-4587-9788-0F4F9056ADC3

P304

Q36553042-EB635FF3-6006-4310-9435-8D259277AE84

P31

Q36553042-956E0BF2-BDFA-42F8-B1C2-2B1BB854C152

P356

Q36553042-E0CD8C44-3E28-4C75-B9E1-93965C08D4F2

P407

Q36553042-3CF6053C-B1A4-4D45-804A-DF76C845D831

P433

Q36553042-909B65CF-8348-4564-9F96-BE0B524D00DF

P478

Q36553042-70AA7ADC-18F8-41D6-81C9-99C3EA6B1936

P50

Q36553042-21D17150-9A6E-46E2-A8A6-C5B6591A5593

P577

Q36553042-A57024C6-289F-4E4C-BBA6-0F096AE37A86

P5875

Q36553042-8C64DCA0-D064-4B00-B3C7-0B1A4B92AD5B

P698

Q36553042-5AE60AC7-53AA-409E-91DD-19405620518E

P921

Q36553042-5C996183-B586-4588-9384-4A9C6B0A7A25

Q36553042-B4DBF81A-9924-4E9E-96CA-A506D60D58A2

Q36553042-D0E9FF97-5CF8-4CCF-8092-91D2807AB1DA

P932

Q36553042-A10A9E38-4CBB-47CB-97CE-0B5691365B85

P356

P1433

British Journal of Cancer

P1476

Differential proteomic alterations between localised and metastatic prostate cancer

@en

P2093

A M Chinnaiyan

http://www.w3.org/2001/XMLSchema#string

B S Taylor

http://www.w3.org/2001/XMLSchema#string

P2860

The Polycomb group protein EZH2 directly controls DNA methylation

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression

Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription

ONCOMINE: a cancer microarray database and integrated data-mining platform

Biomarkers in cancer staging, prognosis and treatment selection

The polycomb group protein EZH2 is involved in progression of prostate cancer

Delineation of prognostic biomarkers in prostate cancer

Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence.

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.

P2888

P304

425-430

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6603274

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Sooryanarayana Varambally

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6905493

http://www.w3.org/2001/XMLSchema#string

P698

16880794

http://www.w3.org/2001/XMLSchema#string

P921

prostate cancer

biomedical investigative technique

neoplasm proteins

P932

2360675

http://www.w3.org/2001/XMLSchema#string